Embecta Corp.
NASDAQ:EMBCDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $345.06M
- Beta
- 0.81
- P/E (TTM)
- 1.6
- EPS (TTM)
- $1.92
- Dividend yield
- 14.79%
Volume 0.72M
Average 1.95M
EMBC Net Income
Bottom-line profit, the starting point for calculating cash from operations.
Embecta Corp.NASDAQ: EMBC
Net Income · Q2 FY2026 · quarter ended Mar 2026
Net income turns negative
Q2 FY2026 net income was -$4.1M, compared with $23.5M a year earlier. Trailing-twelve-month net income was $111.9M. Over 3 fiscal years it compounded at -24.7% a year.
Context
- Net income amounted to 8.8% of revenue in FY2025, up 1.9 pp from a year earlier.
- Net income increased in 2 of the last 3 fiscal years.
What to watch
Whether net income reaches the consensus estimate from 3 analysts of $107.46M (+12.6%) for the fiscal year ending Sep 2026, a slowdown from the +21.8% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$4.1M-109.3% QoQ
- Last fiscal yearSep 2025
- $95.4M+21.8% YoY
- LTMMar 2026
- $111.9M+111.9% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -117.4% | -65.8% | +51.6 pp |
| 1 year | +21.8% | +12.6% | -9.2 pp |
| 3-year CAGR | -24.7% | +3.9% | +28.6 pp |
| 5-year CAGR | +13.6% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 95.4M USD
- Year-over-year change
- +21.8%
- 4-year CAGR
- -30.8%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 95.4M | +21.8% |
| FY2024 | 2024-09-30 | 78.3M | +11.2% |
| FY2023 | 2023-09-30 | 70.4M | -68.5% |
| FY2022 | 2022-09-30 | 223.6M | -46.1% |
| FY2021 | 2021-09-30 | 415M | — |
Net Income vs competitors
How EMBC compares with its peers on the latest reported figures
- EMBC's LTM Mar 2026 net income of $111.9M is the 5th largest of the 11 companies compared; the peer median is $94.61M.
- Its year-over-year change of +111.9% is the 3rd highest of 11, against a peer median of +5.9%.
- Net income amounts to 10.7% of revenue for EMBC, versus a peer median of 46.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $527.72M | +384.3% | +211.5% | 27.9% | |
| LTM Mar 2026 | $442.72M | -23.4% | — | 676.0% | |
| LTM Mar 2026 | $399.9M | +294.4% | +48.4% | 48.2% | |
| LTM Mar 2026 | $198.37M | -1.8% | +18.2% | 4917.6% | |
| LTM Mar 2026 | $111.9M | +111.9% | -24.7% | 10.7% | |
| LTM Jun 2026 | $111.01M | +90.9% | -34.7% | 24.2% | |
| LTM Mar 2026 | $95.55M | +13.7% | -10.5% | 148.1% | |
| LTM Jun 2026 | $93.67M | -68.6% | — | 44.9% | |
| LTM Mar 2026 | $68.91M | +27.1% | +15.5% | 137.1% | |
| LTM Mar 2026 | $20.23M | -58.3% | -11.8% | 21.6% | |
| LTM Mar 2026 | $8.6M | -93.5% | — | 1.3% | |
| Peer median (excluding EMBC) | $94.61M | +5.9% | +15.5% | 46.6% | |
Competitors are the stored peer set for EMBC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Net Income | 415M | 223.6M | 70.4M | 78.3M | 95.4M |
| Depreciation & Amortization | 38M | 31.7M | 32.6M | 36.2M | 40.7M |
| Deferred Income Tax | (2M) | (26.5M) | 14.3M | (70.6M) | 17.6M |
| Stock-Based Compensation | 12.8M | 18.7M | 21.5M | 26.3M | 31.6M |
| Change in Working Capital | (32M) | 92.4M | (80M) | (47.7M) | (23.7M) |
| Accounts Receivables | (32M) | 122.7M | 7M | (174.7M) | 44.2M |
| Inventory | (18M) | (23.4M) | (28.8M) | (16.5M) | (6.1M) |
| Accounts Payables | 30M | 73.3M | 7.9M | 60M | (68.9M) |
| Other Working Capital | (12M) | (80.2M) | (66.1M) | 83.5M | 7.1M |
| Other Non-Cash Items | 24.2M | 72.3M | 8.9M | 13.2M | 30.1M |
| Operating Cash Flow | 456M | 412.2M | 67.7M | 35.7M | 191.7M |
| Capital Expenditures | (39M) | (24M) | (26.5M) | (15.8M) | (9.3M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | (39M) | (24M) | (26.5M) | (15.8M) | (9.3M) |
| Debt Repayment | 0 | 1.44B | (10.7M) | (35.9M) | (186M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (3.6M) | (3M) | (5.7M) |
| Dividends Paid | 0 | (8.6M) | (34.4M) | (34.5M) | (35M) |
| Other Financing Activities | (417M) | (1.48B) | 0 | 0 | 0 |
| Financing Cash Flow | (417M) | (48M) | (48.7M) | (73.4M) | (226.7M) |
| Effect of Forex Changes | 0 | (9.3M) | 3.1M | 1.2M | (1.3M) |
| Net Change in Cash | 0 | 330.9M | (4.4M) | (52.3M) | (45.6M) |
| Free Cash Flow | 417M | 388.2M | 41.2M | 19.9M | 182.4M |
Embecta Corp.
NASDAQ:EMBC
Intrinsic Alpha fair value
Locked
Current Price
$6.09
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.